These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24495095)

  • 1. Actinobacterial enzyme inhibitors--a review.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Crit Rev Microbiol; 2015 Jun; 41(2):261-72. PubMed ID: 24495095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial and fungal protease inhibitors--current and potential applications.
    Sabotič J; Kos J
    Appl Microbiol Biotechnol; 2012 Feb; 93(4):1351-75. PubMed ID: 22218770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine actinobacteria: an important source of bioactive natural products.
    Manivasagan P; Kang KH; Sivakumar K; Li-Chan EC; Oh HM; Kim SK
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):172-88. PubMed ID: 24959957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products.
    Valliappan K; Sun W; Li Z
    Appl Microbiol Biotechnol; 2014 Sep; 98(17):7365-77. PubMed ID: 25064352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecology and genomics of Actinobacteria: new concepts for natural product discovery.
    van Bergeijk DA; Terlouw BR; Medema MH; van Wezel GP
    Nat Rev Microbiol; 2020 Oct; 18(10):546-558. PubMed ID: 32483324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actinobacteriological research in India.
    Velho-Pereira S; Kamat NM
    Indian J Exp Biol; 2013 Aug; 51(8):573-96. PubMed ID: 24228382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxonomy, Physiology, and Natural Products of Actinobacteria.
    Barka EA; Vatsa P; Sanchez L; Gaveau-Vaillant N; Jacquard C; Meier-Kolthoff JP; Klenk HP; Clément C; Ouhdouch Y; van Wezel GP
    Microbiol Mol Biol Rev; 2016 Mar; 80(1):1-43. PubMed ID: 26609051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic biotransformation of terpenes as bioactive agents.
    Sultana N; Saify ZS
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1113-28. PubMed ID: 23046385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinobacterial melanins: current status and perspective for the future.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    World J Microbiol Biotechnol; 2013 Oct; 29(10):1737-50. PubMed ID: 23595596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.
    Masand M; Jose PA; Menghani E; Jebakumar SR
    World J Microbiol Biotechnol; 2015 Dec; 31(12):1863-75. PubMed ID: 26410426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutically active secondary metabolites of marine actinobacteria.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genus Nonomuraea: A review of a rare actinomycete taxon for novel metabolites.
    Sungthong R; Nakaew N
    J Basic Microbiol; 2015 May; 55(5):554-65. PubMed ID: 24633812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodiversity, bioactive natural products and biotechnological potential of plant-associated endophytic actinobacteria.
    Qin S; Xing K; Jiang JH; Xu LH; Li WJ
    Appl Microbiol Biotechnol; 2011 Feb; 89(3):457-73. PubMed ID: 20941490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologically active fungal metabolites.
    Pearce C
    Adv Appl Microbiol; 1997; 44():1-80. PubMed ID: 9311104
    [No Abstract]   [Full Text] [Related]  

  • 15. Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target.
    Ramírez AR; Guerra Y; Otero A; García B; Berry C; Mendiola J; Hernández-Zanui A; Chávez Mde L
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):149-57. PubMed ID: 18471091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein SUMOylation by natural quinones.
    Fukuda I; Hirohama M; Ito A; Tariq M; Igarashi Y; Saitoh H; Yoshida M
    J Antibiot (Tokyo); 2016 Oct; 69(10):776-779. PubMed ID: 26956790
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme inhibitors from marine invertebrates.
    Nakao Y; Fusetani N
    J Nat Prod; 2007 Apr; 70(4):689-710. PubMed ID: 17362037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.
    Wang L; Zhang S; Zhu J; Zhu L; Liu X; Shan L; Huang J; Zhang W; Li H
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1261-4. PubMed ID: 24530004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme inhibitors and other bioactive compounds from marine actinomycetes.
    Imada C
    Antonie Van Leeuwenhoek; 2005 Jan; 87(1):59-63. PubMed ID: 15726292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive Secondary Metabolites with Unique Aromatic and Heterocyclic Structures Obtained from Terrestrial Actinomycetes Species.
    Abdelfattah MS; Arai MA; Ishibashi M
    Chem Pharm Bull (Tokyo); 2016 Jul; 64(7):668-75. PubMed ID: 26936155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.